SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Apthera, Inc. Receives Special Protocol Assessment (SPA) From FDA for Pivotal Phase III Trial of NeuVax in Early-Stage Breast Cancer